ROKEYA TASNIN: Open Payments
NPI 1285820001 · MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,331 in 427 payments from 21 companies in 2025. Trend: 2023 $2,236 · 2024 $2,537 · 2025 $6,331
Food & beverage: $6,327Education: $4
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 36 | $906 |
| E.R. Squibb & Sons, L.L.C. | 57 | $706 |
| Teva Pharmaceuticals USA, Inc. | 45 | $637 |
| Vanda Pharmaceuticals Inc. | 29 | $618 |
| Janssen Pharmaceuticals, Inc | 26 | $561 |
| ABBVIE INC. | 46 | $543 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 42 | $530 |
| Otsuka America Pharmaceutical, Inc. | 46 | $507 |
| Lundbeck LLC | 33 | $427 |
| Alkermes, Inc. | 30 | $322 |
Products named: Auvelity, COBENFY, REXULTI, VRAYLAR, CAPLYTA, AUSTEDO XR, HETLIOZ, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
